Racial and ethnic differences in cardiovascular disease risk factors: a systematic review

Anita K Kurian1, Kathryn M Cardarelli

  • 1School of Public Health, University of North Texas Health Science Center, Plano; Tarrant County Public Health, Fort Worth, Texas, USA. akkurian@tarrantcounty.com

Ethnicity & Disease
|February 6, 2007
PubMed

Insights

Racial and ethnic minorities face higher cardiovascular disease (CVD) risks like hypertension and diabetes. Understanding these disparities is key to developing targeted prevention programs for diverse populations.

Area of Science:

  • Public Health
  • Cardiovascular Medicine
  • Health Disparities Research

Background:

  • Cardiovascular diseases (CVD) are a leading cause of death in the U.S.
  • Racial and ethnic minority populations experience disproportionately higher CVD rates.
  • Understanding modifiable CVD risk factors is crucial for these populations.

Purpose of the Study:

  • To examine factors associated with racial/ethnic disparities in CVD risk factors.
  • To assess differences in hypertension, diabetes, obesity, hypercholesterolemia, physical activity, and smoking by race/ethnicity.
  • To update and expand upon existing reviews of CVD risk factor disparities.

Main Methods:

  • Systematic review of English-language, population-based CVD studies.
  • Inclusion criteria: studies published from 1995 to present with adult populations and ethnic comparisons.
  • Analysis focused on prevalence of key CVD risk factors across different racial/ethnic groups.

Main Results:

  • Hypertension prevalence was significantly higher in Black populations compared to White populations.
  • Minority status was significantly associated with higher diabetes prevalence.
  • Prevalence of obesity and hypercholesterolemia did not consistently differ across minority groups.
  • Smoking rates were lower in Mexican Americans but higher in American Indian/Alaskan Natives (AIANs) compared to Whites.
  • Mexican Americans, AIANs, and Blacks showed higher rates of no leisure-time physical activity.

Conclusions:

  • Significant racial and ethnic disparities exist in cardiovascular disease risk factors.
  • Awareness of these disparities is vital for developing culturally sensitive interventions.
  • Targeted prevention programs and services are needed to address specific risk burdens in diverse populations.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...